APA (7th ed.) Citation

A, P., V, L., Y, M., F, S., B, B., E, R., . . . J, B. (2020). DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus. Drug safety, 43(8), 767. https://doi.org/10.1007/s40264-020-00936-1

Chicago Style (17th ed.) Citation

A, Pariente, Labat V, Mansiaux Y, Salvo F, Bégaud B, Raschi E, Faillie JL, Létinier L, and Bezin J. "DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus." Drug Safety 43, no. 8 (2020): 767. https://doi.org/10.1007/s40264-020-00936-1.

MLA (9th ed.) Citation

A, Pariente, et al. "DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus." Drug Safety, vol. 43, no. 8, 2020, p. 767, https://doi.org/10.1007/s40264-020-00936-1.